Title : Combined targeted therapies in non-small cell lung cancer: a winner strategy?

Pub. Date : 2007 Mar

PMID : 17272980






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 ZD6474 is a dual epidermal growth factor receptor and vascular endothelial growth factor receptor 2 small-molecule tyrosine kinase inhibitor; sorafenib is an oral kinase inhibitor of Raf-1 and is also active against vascular endothelial growth factor receptors 2 and 3, platelet-derived growth factor receptor beta, and c-KIT. vandetanib platelet derived growth factor receptor beta Homo sapiens